Physician profile
Arpitha Polagani
NPI 1467796854
$969.58
in general payments reported to CMS, 2019-2025
9 companies · $89.97 in 2025
The $89.97 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.01 · 2021: $32.27 · 2022: $79.17 · 2023: $756 · 2025: $89.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $574 · Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $574.12 |
| Food and Beverage | $272.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $756.16 | 2023 | |
| Intuitive Surgical, INC. | $66.13 | 2025 | |
| Aspira Women'S Health INC | $50.00 | 2022 | |
| Hologic Sales and Service, LLC | $23.84 | 2025 | Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $20.71 | 2021 | |
| Merck Sharp & Dohme LLC | $17.15 | 2022 | |
| Mayne Pharma Commercial LLC | $12.02 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpitha Polagani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.